Healthcare Professional Blog

Education Library


DanGer Shock Results from Dr. Jacob Møller at ACC 2024

Jacob Møller, MD, the principal investigator of the DanGer Shock trial, discusses study results he presented at ACC 2024.

Sign Up for Latest Updates

Stay up-to-date on the latest clinical data and resources.

All Posts

Ergebnisse filtern





December 5, 2023

Differential Utilization of Impella Devices, ECMO, and Combined Therapies as Escalation and De-escalation Strategies

“The decision to escalate, de-escalate or wean is highly dependent on patient presentation, capabilities of the institution, and the expertise of the heart team,” write the authors of this paper on differential usage of Impella devices, extracorporeal membrane oxygenation (ECMO), and combined str

December 5, 2023

Monitoring on the ICU: Integrating Hemodynamic Assessment, Laboratory Data, and Imaging Techniques for Timely Detection of Deterioration and Recovery

In this paper the authors discuss best practices for monitoring CS patients supported by a microaxial flow pump (mAFP) such as Impella®, venoarterial extracorporeal membrane oxygenation (VA ECMO), or both devices together, a combination referred to as ECpella. 

December 5, 2023

EACTS 2023 Dr. Kaveh Eghbalzadeh: Awake Insertion of Impella 5.5® with SmartAssist®

Kaveh Eghbalzadeh, MD, PhD, describes his first experiences with awake insertion of the Impella 5.5® with SmartAssist® in Cologne.

December 4, 2023

From Medical Therapy to Mechanical Support – Strategies for Device Selection and Insertion Techniques

Letizia Bertoldi, MD, and colleagues describe how catecholamines and percutaneous ventricular assist devices (pVADs) are used to treat cardiogenic shock (CS). Bertoldi et al.

December 1, 2023

Recognizing Patients as Candidates for Mechanical Circulatory Support Along the Spectrum of Cardiogenic Shock

This paper discusses the latest guidance for identifying patients with cardiogenic shock (CS) who are candidates for mechanical circulatory support (MCS).

December 1, 2023

Successful Mechanical Circulatory Support (MCS) in Cardiogenic Shock Patients

Experts throughout Europe have contributed to this European Heart Journal supplement with articles discussing best practices for successfully managing mechanical circulatory support (MCS) in patients with cardiogenic shock.

November 24, 2023

Mario Iannaccone: A Saturday Morning Cardiogenic Shock Case

Mario Iannaccone, MD, discusses how he and his team managed an urgent cardiogenic shock case that arrived on a Saturday morning.

October 30, 2023

EACTS 2023 Evgenij Potapov: pMCS, ECLS, ECMELLA – When, How, and for Whom?

Prof. Evgenij Potapov, MD, discusses temporary MCS options for cardiogenic shock, highlighting the ECMELLA 2+ concept.

October 30, 2023

EACTS 2023 Alexander Bernhardt: Perioperative Use of Impella® Heart Pump in Cardiac Surgery

Alexander Bernhardt, MD, discusses the preoperative, intraoperative, and postoperative use of Impella® in cardiac surgery.

October 30, 2023

EACTS 2023 Scott Silvestry: Impella 5.5® and Impella RP Flex® Heart Pumps in the US

Scott Silvestry, MD, discusses his experience with Impella 5.5® and Impella RP Flex® at EACTS 2023.

August 30, 2023

York Data Analysis About Complete Revascularization With pVAD vs IABP: York I vs York II - A Comparison

Learn more about the data and differences between part I and part II from the York data analysis.

August 30, 2023

Acute Coronary Syndromes and High-Risk PCI: State of the Art - Predictive Value of Residual Syntax Score for Clinical Outcomes After High-Risk Percutaneous Coronary Intervention

In the presentation titled “Predictive value of residual SYNTAX score for clinical outcomes after high-risk percutaneous coronary intervention: Evidence from pooled analysis of prospective studies,” Vasileios Panoulas, MD, and colleagues...

August 29, 2023

ESC 2023: Predictors of 90-day Outcomes from York Analysis

Vasileios Panoulas, MD, discusses a pooled analysis of factors predicting outcomes at 90 days in high-risk PCI patients.

August 14, 2023

Revascularization Completeness with pVAD vs IABP

In a third-party analysis conducted by the York Health Economics Consortium was evaluated to test the hypothesis that percutaneous coronary intervention (PCI) with Impella® support...

Subscribe for Our Healthcare Professional Newsletter

By subscribing you will receive our HeartRecovery newsletter for healthcare professionals with latest Impella® device news about recordings, interviews, upcoming and past events or clinical evidence.


A Community Created by Physicians for Physicians

CAMP PCI was developed by physicians for physicians in an effort to respond to a growing crisis in coronary artery disease and heart failure.


Discover further resources like brochures, data sheets and indications for use.